Gastroenterology & Hepatology Research
Torres profile photo

Innovative Research

Our physician scientists and clinical investigators are leading the way in enhancing the prevention, diagnosis, and treatment of gastrointestinal and hepatology diseases through their research.
Our Research

The U-M Medical School Department of Internal Medicine Division of Gastroenterology and Hepatology has a long tradition of excellence and national leadership in basic science and clinical research and is consistently among the top divisions funded by the National Institutes of Health.

Continuing in this tradition, our division conducts cutting-edge investigations into the molecular, cellular, and physiological conditions of normal and disease states of the gastrointestinal tract, liver, and pancreas, and state-of-the-art clinical research ranging from hepatitis C to Wilson Disease. 

Advanced training and collaborative research involving faculty, fellows, medical students, and graduate students enhance our research endeavors to discover cures and improve clinical outcomes.
Clinical & Research Programs

The Division of Gastroenterology and Hepatology is home to multiple nationally-recognized clinical and research programs.

Learn More About Our Programs
GI & Hepatology Research

Learn more about the Division of Gastroenterology and Hepatology research.

Get to know our faculty and their research

Gut Talk, on Healio Gastroenterology, is a podcast hosted by Dr. Sameer Berry and Dr. William Chey that explores the impact of health policy, technology, practice management, and research on the field of gastroenterology. Listen to the podcast.
T32 Training Programs

Our three-year GI Fellowship Training Program prepares fellows for careers in academic medicine and is separated into three tracks, including two NIH-funded tracks:

  1. NIH-funded T32 Clinical Research track (“Gastroenterology/Research-Outcomes” – NRMP Program Code 1293144F2)
  2. NIH-funded T32 Basic/Translational Research track (“Gastroenterology/Basic Science Research” – NRMP Program Code 1293144F1)

Learn more about the GI fellowship
Featured News & Stories See all news Joy Chang
Department News
Collaborative Management of EoE: Expert Insights from Joy Chang, MD, MS
Joy Chang, MD, MS, explains the importance of collaboration between gastroenterologists and allergists in eosinophilic esophagitis EoE care and praises recent ACG guidelines on disease management.
 pink cells up close
Health Lab
Research links iron-mediated cell death and inflammatory bowel disease
New basic science insights into programmed cell death could offer relief for inflammatory bowel disease. The University of Michigan study reveals a connection between lipid reactive oxygen species, iron-mediated cell death and IBD.
 stethoscope close up black and wood table
Health Lab
Affordable Care Act preventive services mandate key to transforming hepatitis C treatment
In an article researchers describe two potential futures: one in which 90% of hepatitis C cases in the United States are cured within five years and another in which the status quo of insufficient screening rates worsen in the absence of the ACA coverage mandate.
 father and son standing together and book cover
Health Lab
One doctor’s American dream: to stop hate
Asian-American history is American history. William D. Chey shares his immigrant father’s legacy, his own experience and calls on youth to practice the values of diversity, equity and inclusion throughout their lives.
 cutting board close up person cutting food with olive oil on side
Health Lab
Mediterranean diet provides symptom relief for patients with IBS in pilot study
A pilot study found that the Mediterranean diet may provide symptom relief for people with irritable bowel syndrome commonly referred to as IBS.
 red cancer cell on red background
Health Lab
Researchers identify roles of key genes in colon cancer development
Researchers used mouse models and studies of colorectal cancer tissues to show that loss of SOX9 gene promotes tumor progression and the pathway it regulates can be a potential target for future treatments.